What is the clinical significance of a 2.5 cm axillary lymph node with a central fatty hilum?

A 2.5 cm Axillary Lymph Node with Central Fatty Hilum is Likely Benign and Generally Does Not Require Biopsy

The presence of a preserved fatty hilum is the single most reassuring feature on imaging, with the highest negative predictive value (90-93%) for malignancy, making this finding likely benign despite the size. 1

Key Imaging Features and Their Significance

The Fatty Hilum: Most Important Predictor

The presence of a fatty hilum is statistically the strongest predictor of benign disease (OR = 0.019,95% CI = 0.002-0.153, p < 0.001), markedly lowering the likelihood of lymph node metastasis 2. This feature has the highest positive predictive value (90-93%) for benignancy when present 1.

In patients with known breast cancer, the odds of malignancy increase 27-fold when the hilum is absent, but conversely, a preserved hilum is highly protective 3. The absence of a fatty hilum has the highest PPV (90-93%) for malignancy, meaning its presence strongly suggests benignity 1.

Size Considerations

While this node measures 2.5 cm (larger than typical screening thresholds), size alone is less predictive than morphologic features:

• Traditional screening criteria use >2 cm as a cutoff for "pathological" nodes 4
• However, cortical thickness >3 mm is more specific than overall size 1
• In patients without breast cancer, an 11 mm cortical thickness had only 30% likelihood of malignancy, whereas in breast cancer patients, a 3 mm cortical thickness had 30% likelihood 3

The critical measurement is cortical thickness, not total node size. If the cortex is <3-4 mm and the fatty hilum is preserved, the node is likely reactive/benign regardless of overall dimensions.

Clinical Context Determines Management

Without Known Breast Cancer

If this is an incidental finding in a patient without breast cancer:

• Observation is reasonable if the fatty hilum is intact and cortical thickness is <4 mm
• Consider clinical correlation for infectious, inflammatory, or rheumatologic causes
• If truly isolated lymphadenopathy on screening mammography with no known cause, there is a 52% malignancy rate (including lymphoma and metastatic disease), warranting FNA followed by excision biopsy if positive 4

With Known Breast Cancer

In breast cancer patients, the ACR Appropriateness Criteria recommend 1:

• Axillary ultrasound is the primary modality for evaluation
• Biopsy is indicated when nodes show: absent fatty hilum, cortical thickness >3 mm, or rounded morphology
• A preserved fatty hilum with normal cortical thickness (<3 mm) suggests the node is benign, even if enlarged

Recommended Approach

For this specific 2.5 cm node with preserved fatty hilum:

1. Assess cortical thickness precisely - if <3-4 mm, strongly favors benign etiology

2. Evaluate for other suspicious features:

   • Shape (rounded vs. reniform)
   • Cortical thickening pattern (focal vs. diffuse)
   • Vascularity pattern
   • Presence of "flare sign" (perinodal signal suggesting extranodal extension) 2

3. Clinical correlation:

   • History of breast cancer or other malignancy?
   • Recent infections, vaccinations (including COVID-19), or inflammatory conditions?
   • Presence of tattoos (pigment can migrate to nodes and mimic calcifications) 5

4. If all features are reassuring (preserved hilum, thin cortex <3-4 mm, oval shape):

   • No biopsy needed - follow clinically or with short-interval imaging if clinically indicated
   • Size alone does not mandate intervention when morphology is benign

5. If any suspicious features present (absent hilum, thick cortex >3-4 mm, rounded shape):

   • US-guided core needle biopsy preferred over FNA (sensitivity 88% vs 74%) 1

Common Pitfalls to Avoid

• Don't biopsy based on size alone - morphology trumps size for predicting malignancy
• Don't assume all enlarged nodes in breast cancer patients are metastatic - reactive adenopathy is common
• Don't rely on ultrasound alone without biopsy if suspicious features are present - US sensitivity ranges widely (26-94%) and cannot definitively exclude malignancy 1
• Don't forget non-breast malignancies - lymphoma and other metastatic diseases can present as axillary adenopathy 4

In summary: A 2.5 cm axillary node with an intact fatty hilum and normal cortical thickness is most likely benign reactive adenopathy and does not require biopsy unless other clinical or imaging features raise concern.